Contact Careers rss
 

Global HIV Vaccine Enterprise Hails Significant Results from HIV Vaccine Study in Thailand

Results of the Thai HIV vaccine clinical trial of the “prime-boost” combination of ALVAC-HIV vaccine and AIDSVAC B/E vaccine demonstrate that a safe and effective AIDS vaccine is an achievable goal. For more information, please see the Enterprise statement below.

Attachment Size
ThaiTrialStatementFINAL.pdf 27.7 KB
Global HIV Vaccine Enterprise, 200 Park Ave. S. Suite 1501, New York, NY 10003 | +1 212-461-3692 or toll free at +1-866-966-4483

All Content ©2005 - 2009 Global HIV Vaccine Enterprise   |   Terms of Use   |   Privacy Policy   |   Log In / My Account